Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Clostridium difficile is an opportunistic human intestinal pathogen, and C. difficile infection (CDI) is one of the main causes of antibiotic-induced diarrhea and colitis. One successful approach to combat CDI, particularly recurrent form of CDI, is through transplantation of fecal microbiota from a healthy donor to the infected patient. In this study we investigated the distal gut microbial communities of three CDI patients before and after fecal microbiota transplantation, and we compared these communities to the composition of the donor's fecal microbiota. We utilized phylogenetic Microbiota Array, high-throughput Illumina sequencing, and fluorescent in situ hybridization to profile microbiota composition down to the genus and species level resolution. RESULTS: The original patients' microbiota had low diversity, was dominated by members of Gammaproteobacteria and Bacilli, and had low numbers of Clostridia and Bacteroidia. At the genus level, fecal samples of CDI patients were rich in members of the Lactobacillus, Streptococcus, and Enterobacter genera. In comparison, the donor community was dominated by Clostridia and had significantly higher diversity and evenness. The patients' distal gut communities were completely transformed within 3 days following fecal transplantation, and these communities remained stable in each patient for at least 4 months. Despite compositional differences among recipients' pre-treatment gut microbiota, the transplanted gut communities were highly similar among recipients post-transplantation, were indistinguishable from that of the donor, and were rich in members of Blautia, Coprococcus, and Faecalibacterium. In each case, the gut microbiota restoration led to a complete patient recovery and symptom alleviation. CONCLUSION: We conclude that C. difficile infection can be successfully treated by fecal microbiota transplantation and that this leads to stable transformation of the distal gut microbial community from the one abundant in aerotolerant species to that dominated by members of the Clostridia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, additional clinical evidence has proven no association between donor and FMT outcomes.53,54”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549 · cited 1×
“Sequence data were processed and analyzed using the MOTHUR program [18].”
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762 · cited 1×
“Sequences were clustered into OTUs using the furthest neighbor algorithm with a 90% cutoff [19].”
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 4×
“While several previous reports have evaluated microbiota alterations following FMT therapy in human patients [7-9,23,24], the genus and species level changes were explored only in few studies [25].”
InfluentialDysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713 · cited 1×
“In addition to the tolerance against molecular oxygen and its effects, these oxidative stress response genes also provide protection against ROS generated by neutrophils and macrophages and released into the gut during inflammation [34].”
Multivariate analyses in microbial ecology
Ramette, A. (2007) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2007.00375.x · Cited by 1,928 · cited 1×
“Consistent with our analysis as described above, there was a considerable difference in the community phylotype structure between the CDI and donor samples, and this difference was the largest determinant of dataset variability, because the donor and CDI samples were separated along the principal component/coordinate…”
Moving pictures of the human microbiome
Caporaso, J. G., Lauber, C. L., Costello, E. K., Berg-Lyons, D., Gonzalez, A., Stombaugh, J., Knights, D., Gajer, P., Ravel, J., Fierer, N., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-5-r50 · Cited by 1,138 · cited 1×
“In contrast to the fecal communities of CDI patients, the fecal samples of the donor were dominated by members of Clostridia, Actinobacteria, Erysipelotrichi, and Bacteroidia, which is a common composition of the distal gut microbiota in healthy humans [43].”
Hamady, M., Lozupone, C., & Knight, R. (2010) · The ISME Journal · doi:10.1038/ismej.2009.97 · Cited by 1,099 · cited 1×
“PCoA analyses were carried out on the Fast UniFrac web server [17].”
Willing, B. P., Dicksved, J., Halfvarson, J., Andersson, A. F., Lucio, M., Zheng, Z., Järnerot, G., Tysk, C., Jansson, J. K., & Engstrand, L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.049 · Cited by 1,032
Treating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003
Hamilton, M. J., Weingarden, A. R., Sadowsky, M. J., & Khoruts, A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.482 · Cited by 738 · cited 7×
“Ulcerative colitis, a common coexisting condition in patients with recurrent CDI [14,26], may have contributed to dysbiosis in patient”
InfluentialPetrof, E. O., Gloor, G. B., Vanner, S. J., Weese, S. J., Carter, D., Daigneault, M. C., Brown, E. M., Schroeter, K., & Allen-Vercoe, E. (2013) · Microbiome · doi:10.1186/2049-2618-1-3 · Cited by 731 · cited 2×
“While several previous reports have evaluated microbiota alterations following FMT therapy in human patients [7-9,23,24], the genus and species level changes were explored only in few studies [25].”
Zoetendal, E. G., Raes, J., van den Bogert, B., Arumugam, M., Booijink, C. C. G. M., Troost, F. J., Bork, P., Wels, M., de Vos, W. M., & Kleerebezem, M. (2012) · The ISME Journal · doi:10.1038/ismej.2011.212 · Cited by 722 · cited 1×
“Interestingly, both of these abundant taxons contain many facultative anaerobic or aerotolerant bacteria, and many are known to be abundant in the human ileum, in part due to their ability to tolerate the presence of oxygen [28-33].”
Fecal microbiota transplantation and emerging applications
Borody, T. J., & Khoruts, A. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.244 · Cited by 677 · cited 1×
“factor, are possible candidates to which FMT could be applied with success [47,48].”
Self-citationKhoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 3×
“Recent studies from our group showed that the eradication of the disease symptoms is accompanied by a dramatic shift in the microbial community as examined by TRFLP and gene sequencing analyses [8,9].”
Self-citationDiverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing
Eyre, D. W., Cule, M. L., Wilson, D. J., Griffiths, D., Vaughan, A., O'Connor, L., Ip, C. L. C., Golubchik, T., Batty, E. M., Finney, J. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1216064 · Cited by 648 · cited 1×
“Other reservoirs of CDI can also exist according to a recent report [5].”
Antharam, V. C., Li, E. C., Ishmael, A., Sharma, A., Mai, V., Rand, K. H., & Wang, G. P. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00845-13 · Cited by 485 · cited 1×
“These genera were found to be highly abundant in the fecal samples of CDI patients, an observation partially matched by the analysis of CDI microbiota by Anthraham and colleagues [35].”
Multilocus Sequence Typing of Clostridium difficile
Griffiths, D., Fawley, W., Kachrimanidou, M., Bowden, R., Crook, D. W., Fung, R., Golubchik, T., Harding, R. M., Jeffery, K. J. M., Jolley, K. A., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01796-09 · Cited by 475
Clostridium difficile Infection
Kelly, C. P., & LaMont, J. T. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.375 · Cited by 420
The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession.
Reuter, G. (2001) · PubMed · Cited by 416
Espey, M. G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.554 · Cited by 396 · cited 1×
“2) Because diarrhea in combination with antibiotic administration during standard CDI treatment are expected to reduce the overall counts of microbes in the colon [38], this may increase the average oxygen level in that gut region (typically less than 1% [39]).”
Clostridium difficile infection: epidemiology, risk factors and management
Ananthakrishnan, A. N. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.190 · Cited by 352 · cited 1×
“Ulcerative colitis, a common coexisting condition in patients with recurrent CDI [14,26], may have contributed to dysbiosis in patient”
Agans, R., Rigsbee, L., Kenche, H., Michail, S., Khamis, H. J., & Paliy, O. (2011) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2011.01120.x · Cited by 343 · cited 1×
“Microarray hybridization, washing, and scanning were carried out as described previously [12,16].”
Self-citationFecal microbiota transplantation: past, present and future
Aroniadis, O. C., & Brandt, L. J. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a4b3e · Cited by 336 · cited 1×
“factor, are possible candidates to which FMT could be applied with success [47,48].”
Reshaping the gut microbiome with bacterial transplantation and antibiotic intake
Manichanh, C., Reeder, J., Gibert, P., Varela, E., Llopis, M., Antolin, M., Guigo, R., Knight, R., & Guarner, F. (2010) · Genome Research · doi:10.1101/gr.107987.110 · Cited by 335 · cited 1×
“2) Because diarrhea in combination with antibiotic administration during standard CDI treatment are expected to reduce the overall counts of microbes in the colon [38], this may increase the average oxygen level in that gut region (typically less than 1% [39]).”
High temporal and inter‐individual variation detected in the human ileal microbiota
Booijink, C. C. G. M., El‐Aidy, S., Rajilić‐Stojanović, M., Heilig, H. G. H. J., Troost, F. J., Smidt, H., Kleerebezem, M., De Vos, W. M., & Zoetendal, E. G. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02294.x · Cited by 324
Hamilton, M. J., Weingarden, A. R., Unno, T., Khoruts, A., & Sadowsky, M. J. (2013) · Gut Microbes · doi:10.4161/gmic.23571 · Cited by 315 · cited 7×
“Recent studies from our group showed that the eradication of the disease symptoms is accompanied by a dramatic shift in the microbial community as examined by TRFLP and gene sequencing analyses [8,9].”
InfluentialSelf-citationSwidsinski, A., Loening-Baucke, V., Vaneechoutte, M., & Doerffel, Y. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20330 · Cited by 276 · cited 1×
“difficile infection is associated with frequent diarrhea, it usually leads to a significantly shortened transit time in the large intestine [36], and diarrhea would result in a lower overall load of microbes in the colon [37].”
Why Metronidazole Is Active against both Bacteria and Parasites
Samuelson, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1533 · Cited by 231 · cited 1×
“Since metronidazole predominantly targets anaerobic bacteria [41], and vancomycin inhibits cell wall synthesis of gram-positive bacteria [42], the use of these antibiotics would be expected to reduce members of class Clostridia (most are strictly anaerobic gram-positive species) and not affect Proteobacteria (many are…”
Curry, S. R., Muto, C. A., Schlackman, J. L., Pasculle, A. W., Shutt, K. A., Marsh, J. W., & Harrison, L. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit475 · Cited by 228 · cited 1×
“difficile spores are often acquired nosocomially, and as a result, a high incidence of CDI is seen among hospitalized patients, in the outpatient community, and among nursing home residents [3,4].”
Rigsbee, L., Agans, R., Shankar, V., Kenche, H., Khamis, H. J., Michail, S., & Paliy, O. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.287 · Cited by 207 · cited 15×
“Microbiota Arrays contain probes targeting full-length 16S rRNA genes of 775 human microbiota phylotypes and allows direct comparison of taxon abundances between samples [10].”
InfluentialSelf-citationBile salt malabsorption in regional ileitis, ileal resection, and mannitol-induced diarrhea
Meihoff, W. E., & Kern, F. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105722 · Cited by 200 · cited 1×
“difficile infection is associated with frequent diarrhea, it usually leads to a significantly shortened transit time in the large intestine [36], and diarrhea would result in a lower overall load of microbes in the colon [37].”
Mode of action and in-vitro activity of vancomycin
Watanakunakorn, C. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.suppl_d.7 · Cited by 197
Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., Weese, S., Wong, A., Low, D. E., & Pillai, D. R. (2012) · mBio · doi:10.1128/mbio.00338-12 · Cited by 191 · cited 2×
“While several previous reports have evaluated microbiota alterations following FMT therapy in human patients [7-9,23,24], the genus and species level changes were explored only in few studies [25].”
van den Bogert, B., de Vos, W. M., Zoetendal, E. G., & Kleerebezem, M. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02477-10 · Cited by 174 · cited 1×
“Interestingly, both of these abundant taxons contain many facultative anaerobic or aerotolerant bacteria, and many are known to be abundant in the human ileum, in part due to their ability to tolerate the presence of oxygen [28-33].”
Song, Y., Garg, S., Girotra, M., Maddox, C., von Rosenvinge, E. C., Dutta, A., Dutta, S., & Fricke, W. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081330 · Cited by 172 · cited 1×
“Such microbiota restructuring after FMT was also noted in our previous reports as well as in several other studies [8,9,24,44].”
Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis
Jarchum, I., Liu, M., Shi, C., Equinda, M., & Pamer, E. G. (2012) · Infection and Immunity · doi:10.1128/iai.00448-12 · Cited by 152
Manges, A. R., Labbe, A., Loo, V. G., Atherton, J. K., Behr, M. A., Masson, L., Tellis, P. A., & Brousseau, R. (2010) · The Journal of Infectious Diseases · doi:10.1086/657319 · Cited by 149 · cited 1×
“While several previous reports have evaluated microbiota alterations following FMT therapy in human patients [7-9,23,24], the genus and species level changes were explored only in few studies [25].”
Guo, B., Harstall, C., Louie, T., Veldhuyzen van Zanten, S., & Dieleman, L. A. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05033.x · Cited by 135 · cited 1×
“Several reports have indicated the overwhelming clinical efficacy of FMT [7,14,45,46].”
Paliy, O., Kenche, H., Abernathy, F., & Michail, S. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.02764-08 · Cited by 119 · cited 16×
“Microbiota Arrays contain probes targeting full-length 16S rRNA genes of 775 human microbiota phylotypes and allows direct comparison of taxon abundances between samples [10].”
InfluentialLandy, J., Al-Hassi, H. O., McLaughlin, S. D., Walker, A. W., Ciclitira, P. J., Nicholls, R. J., Clark, S. K., & Hart, A. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04737.x · Cited by 100 · cited 1×
“Several reports have indicated the overwhelming clinical efficacy of FMT [7,14,45,46].”
Anderson, C. M., & Langford, R. F. (1958) · BMJ · doi:10.1136/bmj.1.5074.803 · Cited by 73 · cited 1×
“Interestingly, both of these abundant taxons contain many facultative anaerobic or aerotolerant bacteria, and many are known to be abundant in the human ileum, in part due to their ability to tolerate the presence of oxygen [28-33].”
High Prevalence of Clostridium difficile Colonization among Nursing Home Residents in Hesse, Germany
Arvand, M., Moser, V., Schwehn, C., Bettge-Weller, G., Hensgens, M. P., & Kuijper, E. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030183 · Cited by 71
Antibiotics—Past, Present, and Future
Khardori, N. M. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.06.007 · Cited by 50
Do gut microbial communities differ in pediatric IBS and health?
Shankar, V., Agans, R., Holmes, B., Raymer, M., & Paliy, O. (2013) · Gut Microbes · doi:10.4161/gmic.24827 · Cited by 36 · cited 12×
“Microbiota Arrays contain probes targeting full-length 16S rRNA genes of 775 human microbiota phylotypes and allows direct comparison of taxon abundances between samples [10].”
InfluentialRigsbee, L., Agans, R., Foy, B. D., & Paliy, O. (2011) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2010.01009.x · Cited by 34 · cited 15×
“Microbiota Arrays contain probes targeting full-length 16S rRNA genes of 775 human microbiota phylotypes and allows direct comparison of taxon abundances between samples [10].”
InfluentialThe micro-flora of the small bowel in health and disease
Sullivan, Å., Törnblom, H., Lindberg, G., Hammarlund, B., Ac, P., Einarsson, C., & Nord, C. E. (2003) · Anaerobe · doi:10.1016/s1075-9964(03)00060-x · Cited by 32 · cited 1×
“Interestingly, both of these abundant taxons contain many facultative anaerobic or aerotolerant bacteria, and many are known to be abundant in the human ileum, in part due to their ability to tolerate the presence of oxygen [28-33].”
Paliy, O., & Foy, B. D. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr326 · Cited by 24 · cited 2×
“The full length bacterial 16S rRNA gene was amplified from genomic DNA with degenerate primers Bact-27Fv4 (5′-AGRGTTYGA TYMTGGCTCAG-3′) and Univ-1492Rv1 (5′-GGHTA CCTTGTTACGACTT-3′) [10] [15].”
Cited by
Kelly, C. R., Khoruts, A., Staley, C., Sadowsky, M. J., Abd, M., Alani, M., Bakow, B., Curran, P., McKenney, J., Tisch, A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0271 · Cited by 613
“Prior Lactobacillus GG use, n (%) 5 (23) 3 (13)”
BackgroundResultFecal microbiota transplantation: Review and update
Wang, J.-W., Kuo, C.-H., Kuo, F.-C., Wang, Y.-K., Hsu, W.-H., Yu, F.-J., Hu, H.-M., Hsu, P.-I., Wang, J.-Y., & Wu, D.-C. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.08.011 · Cited by 576
Understanding the mechanisms of faecal microbiota transplantation
Khoruts, A., & Sadowsky, M. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.98 · Cited by 561
Application of multivariate statistical techniques in microbial ecology
Paliy, O., & Shankar, V. (2016) · Molecular Ecology · doi:10.1111/mec.13536 · Cited by 452
“at least 70 days, confirming a previously reported observation (Shankar et al. 2014).”
BackgroundMethodResultInfluentialThe Super-Donor Phenomenon in Fecal Microbiota Transplantation
Wilson, B. C., Vatanen, T., Cutfield, W. S., & O'Sullivan, J. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00002 · Cited by 413
“Microbial analyses carried out on CDI patients before and after FMT have confirmed FMT is rapidly capable of restoring microbial diversity in patients to donor-like proportions (Song et al., 2013; Shankar et al., 2014; Kelly et al., 2016; Staley et al., 2016; Khanna et al., 2017; Kellingray et al., 2018).”
Background
Metadata
- Authors
- Shankar, V., Hamilton, M. J., Khoruts, A., Kilburn, A., Unno, T., Paliy, O., & Sadowsky, M. J.
- Affiliations
- Wright State University (US)
- University of Minnesota (US)
- Corresponding author
- Paliy, Oleg
- Sadowsky, Michael J
- Venue
- Microbiome
- Published
- 2014-04-21
- Volume
- 2
- Issue
- 1
- Pages
- 13-13
- ISSN
- 2049-2618 (ISSN-L)
- PMC
- PMC4030581
- OpenAlex
- W2156875941
- Cited by
- 106
- References
- 48
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 7 · 2022: 2 · 2021: 13 · 2020: 9 · 2019: 13 · 2018: 4 · 2017: 15 · 2016: 17 · 2015: 17 · 2014: 2
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Microbiome (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AT003423)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile infection, fecal microbiota transplantation, gut microbiota, Clostridia, donor microbiota, microbial community composition, species-level resolution, recurrent Clostridium difficile infection, antibiotic-associated diarrhea, Blautia, Coprococcus, Faecalibacterium, Lactobacillus, Streptococcus, Enterobacter, microbial diversity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.